44 related articles for article (PubMed ID: 35504427)
1. Surfactants influence polymer nanoparticle fate within the brain.
Joseph A; Simo GM; Gao T; Alhindi N; Xu N; Graham DJ; Gamble LJ; Nance E
Biomaterials; 2021 Oct; 277():121086. PubMed ID: 34481289
[TBL] [Abstract][Full Text] [Related]
2. Polysorbate 80 coated chitosan nanoparticles for delivery of α-melanocyte stimulating hormone analog (NDP-MSH) to the brain reverse cognitive impairment related to neuroinflammation produced by a high-fat diet (HFD).
Herrera G; Scimonelli T; Lasaga M; Granero G; Onnainty R
Neuropharmacology; 2024 Aug; 253():109969. PubMed ID: 38688422
[TBL] [Abstract][Full Text] [Related]
3. Drug transport to brain with targeted nanoparticles.
Olivier JC
NeuroRx; 2005 Jan; 2(1):108-19. PubMed ID: 15717062
[TBL] [Abstract][Full Text] [Related]
4. Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin.
Li Z; Kovshova T; Malinovskaya J; Knoll J; Shanehsazzadeh S; Osipova N; Chernysheva A; Melnikov P; Gelperina S; Wacker MG
Int J Nanomedicine; 2024; 19():2039-2056. PubMed ID: 38476274
[TBL] [Abstract][Full Text] [Related]
5. Effect of surfactants on lactate dehydrogenase aqueous solutions: A comparative study of poloxamer 188, polysorbate 20 and 80.
Li J; Zeng C; Guan J; Suryanarayanan R
Int J Pharm; 2024 Jun; 661():124374. PubMed ID: 38909927
[TBL] [Abstract][Full Text] [Related]
6. Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
Hamadani CM; Mahdi F; Merrell A; Flanders J; Cao R; Vashisth P; Dasanayake GS; Darlington DS; Singh G; Pride MC; Monroe WG; Taylor GR; Hunter AN; Roman G; Paris JJ; Tanner EEL
Adv Sci (Weinh); 2024 Jun; 11(23):e2305484. PubMed ID: 38572510
[TBL] [Abstract][Full Text] [Related]
7. PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study.
Hoyos-Ceballos GP; Ruozi B; Ottonelli I; Da Ros F; Vandelli MA; Forni F; Daini E; Vilella A; Zoli M; Tosi G; Duskey JT; López-Osorio BL
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31963430
[TBL] [Abstract][Full Text] [Related]
8. Gold nanocarriers for transport of oligonucleotides across brain endothelial cells.
Fatima N; Gromnicova R; Loughlin J; Sharrack B; Male D
PLoS One; 2020; 15(9):e0236611. PubMed ID: 32941446
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Biopharmaceutically Relevant Nonionic Surfactant Excipients Using Benchtop qNMR.
Lynch CC; Khirich G; Lee RT
Anal Chem; 2024 Apr; 96(17):6746-6755. PubMed ID: 38632675
[TBL] [Abstract][Full Text] [Related]
10. Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
Hamadani CM; Mahdi F; Merrell A; Flanders J; Cao R; Vashisth P; Pride MC; Hunter AN; Singh G; Roman G; Paris JJ; Tanner EEL
Res Sq; 2023 Feb; ():. PubMed ID: 36824802
[TBL] [Abstract][Full Text] [Related]
11. Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.
Mészáros M; Phan THM; Vigh JP; Porkoláb G; Kocsis A; Páli EK; Polgár TF; Walter FR; Bolognin S; Schwamborn JC; Jan JS; Deli MA; Veszelka S
Cells; 2023 Feb; 12(3):. PubMed ID: 36766845
[TBL] [Abstract][Full Text] [Related]
12. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
13. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
14. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles.
Vilella A; Ruozi B; Belletti D; Pederzoli F; Galliani M; Semeghini V; Forni F; Zoli M; Vandelli MA; Tosi G
Pharmaceutics; 2015 Jun; 7(2):74-89. PubMed ID: 26102358
[TBL] [Abstract][Full Text] [Related]
16. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells.
Moya ELJ; Lombardo SM; Vandenhaute E; Schneider M; Mysiorek C; Türeli AE; Kanda T; Shimizu F; Sano Y; Maubon N; Gosselet F; Günday-Türeli N; Dehouck MP
Int J Pharm; 2022 Jun; 621():121780. PubMed ID: 35504427
[TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
